How is rhabdomyolysis diagnosed?

Diagnosis of Rhabdomyolysis

Rhabdomyolysis is diagnosed by the combination of clinical symptoms (severe muscle pain, weakness, or swelling), markedly elevated serum creatine kinase (CK) levels exceeding 5,000 IU/L for non-exertional cases or 10,000 IU/L for exertional cases, and characteristic laboratory findings including myoglobinuria. 1

Core Diagnostic Criteria

The diagnosis requires three essential components working together:

Clinical Presentation

• Severe muscle symptoms including muscle pain (myalgia), weakness, and/or swelling are required for diagnosis 1
• Dark or tea-colored urine indicating myoglobinuria is a classic finding 2, 3
• Symptoms typically develop over hours to days after an inciting event 2

Laboratory Thresholds

CK elevation is the cornerstone of diagnosis, with specific thresholds based on context:

• Non-exertional rhabdomyolysis: CK >5,000 IU/L 1
• Exertional rhabdomyolysis: CK >10,000 IU/L 1
• Patients with underlying neuromuscular conditions: CK should exceed 5-10 times their baseline level 1

Important timing consideration: CK levels peak 24-120 hours after the inciting event, not immediately, so early testing may underestimate severity 4, 1. CK should reach maximum 1-4 days after the event and normalize within 1-2 weeks of rest 1.

Urinalysis Findings

• Positive for blood without red blood cells (indicating myoglobinuria) is diagnostic 4
• Brown, cloudy urine appearance 4
• Serum myoglobin can be detected earlier than CK but has a shorter half-life 5

Essential Initial Laboratory Workup

Beyond CK, a comprehensive metabolic assessment is critical to identify life-threatening complications:

Immediate Priority Tests

• Complete electrolyte panel to assess for hyperkalemia (can cause fatal arrhythmias), hypocalcemia, and hyperphosphatemia 4, 5
• Renal function tests (BUN and creatinine) to monitor for acute kidney injury 5
• Urinalysis for myoglobinuria 4
• ECG to detect cardiac arrhythmias from electrolyte abnormalities 5

Additional Diagnostic Tests

• Liver function tests (AST, ALT, alkaline phosphatase) as transaminases are commonly elevated due to muscle enzyme release 4, 5
• Coagulation studies to evaluate for disseminated intravascular coagulation in severe cases 4, 5
• Arterial blood gas to assess for metabolic acidosis 4, 5
• Cardiac troponin in severe cases to rule out cardiac involvement 4, 5
• Complete blood count to evaluate for infection or systemic processes 4

Critical pitfall: Use total CK, not CK-MB, for rhabdomyolysis diagnosis. CK-MB lacks sensitivity and specificity for rhabdomyolysis and can be falsely elevated from skeletal muscle injury without cardiac involvement 4.

Risk Stratification for Complications

The myoglobin-to-CK ratio is the strongest predictor of acute kidney injury (AKI), superior to CK or myoglobin alone:

• Ratio ≥0.48 has 79% sensitivity and 82% specificity for AKI 6
• Combined with myoglobin ≥4,489 ng/mL, this identifies 89% of AKI cases 6
• The McMahon score is useful for identifying patients at highest risk for serious complications 7, 1

Etiology-Specific Testing

When the cause is unclear or recurrent episodes occur, additional workup is warranted:

Medication and Toxin Screen

• Document all medications, particularly statins, which cause rhabdomyolysis at 1.6 per 100,000 patient-years 4
• Screen for recreational drugs (cocaine, methamphetamine, MDMA, ketamine, heroin) 4
• Review supplements including red yeast rice, creatine monohydrate, wormwood oil, licorice, and Hydroxycut 4

Genetic and Metabolic Testing (for recurrent or unexplained cases)

• RYR1 and CACNA1S gene sequencing for malignant hyperthermia susceptibility in exertional rhabdomyolysis 4, 5
• CPT2, PYGM, ACADM, AMPD1, VLCAD gene testing for metabolic myopathies causing recurrent episodes 4
• Calcium, phosphorus, alkaline phosphatase, PTH, and vitamin D if metabolic disorder suspected 4

Autoimmune Evaluation (if inflammatory myositis suspected)

• Autoimmune markers (ANA, ASMA, ANCA) 4, 5
• Anti-Mi-2 antibodies for dermatomyositis 8
• EMG and MRI may differentiate inflammatory myositis from rhabdomyolysis 5
• Muscle biopsy in select cases for definitive diagnosis 2, 8

Infectious Workup

• Viral studies if viral myositis suspected 4, 5
• Consider Rocky Mountain Spotted Fever in patients with fever, headache, myalgia, and rash 9

Monitoring During Treatment

Serial measurements are essential to track disease progression and response:

• For severe rhabdomyolysis (CK >5,000 IU/L): Monitor CK, electrolytes, and renal function every 6-12 hours initially 5
• Once CK begins declining: Reduce monitoring to daily 5
• Continue until: CK is declining and renal function is stable 4

Special Diagnostic Considerations

Compartment Syndrome Assessment

In traumatic cases, evaluate for compartment syndrome, which both causes and complicates rhabdomyolysis:

• Early signs: Pain, tension, paresthesia, and paresis 4, 5
• Late signs: Pulselessness and pallor (indicate irreversible damage) 4
• Fasciotomy indicated when compartment pressure >30 mmHg or differential pressure (diastolic BP - compartment pressure) <30 mmHg 4

Trauma-Related Pitfall

Impact trauma from falls can drastically elevate CK without true muscle breakdown 4. However, CK elevation from simple contusion peaks 24-120 hours post-event, so if CK is rising or clinical suspicion remains high, repeat measurement at 24 hours 4.

Altered Mental Status

When patients present with altered mental status and elevated CK, determine whether AMS is:

• A precipitating cause (seizures, prolonged immobilization, drug intoxication)
• A consequence of rhabdomyolysis (electrolyte disturbances, uremia from AKI)
• An unrelated complicating condition (neuroleptic malignant syndrome, serotonin syndrome) 4

Referral Indications

Refer for malignant hyperthermia susceptibility testing in cases of exertional rhabdomyolysis, recurrent episodes, or persistently elevated CK with no identified cause after neurological workup 5.